The Food and Drug Administration reported a shortage of Bristol-Myers Squibb's cancer drug Etopophos as of Sept. 16.
Etopophos is used to treat testicular cancer and small cell lung cancer. The drug is on backorder due to a raw materials shortage of one of the drug's active ingredients.
New York City-based Bristol-Myers Squibb is working to resolve the issue as soon as possible and expects the drug to be available again September 2017.
More articles on supply chain:
Jimmy Kimmel's EpiPen joke calls out high drug prices at Emmys
Ohio police race through anti-overdose drug supply
Sarepta's muscular dystrophy drug to cost $300k a year